Patents by Inventor Friederike Jayes

Friederike Jayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human sperm specific lysozyme-like proteins
    Patent number: 7125550
    Abstract: The present invention relates to two novel, testis-specific proteins (C19 and C23) that arc lysozyme paralogues. The proteins are believed to play a role in capacitation of sperm and the fertilization of the ovum. Therefore these compounds make ideal targets for the design of contraceptive agents. The C19 and C23 proteins can also be modified to establish lysozyme activity and the modified proteins can then be used in all applications that currently exist for lysozymes.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: October 24, 2006
    Assignee: University of Virginia Patent Foundation
    Inventors: John C. Herr, Friederike Jayes, Arabinda Mandal, Jagathpala Shetty, Michael J. Wolkowicz
  • Sperm specific lysozyme-like proteins
    Publication number: 20060062799
    Abstract: The present invention relates to two novel, testis-specific proteins (C19 and C23) that are lysozyme paralogues. The proteins are believed to play a role in capacitation of sperm and the fertilization of the ovum. Therefore these compounds make ideal targets for the design of contraceptive agents. The C19 and C23 proteins can also be modified to establish lysozyme activity and the modified proteins can then be used in all applications that currently exist for lysozymes.
    Type: Application
    Filed: November 8, 2005
    Publication date: March 23, 2006
    Inventors: John Herr, Friederike Jayes, Arabinda Mandal, Jagathpala Shetty, Michael Wolkowicz
  • Human sperm specific lysozyme-like proteins
    Publication number: 20030129652
    Abstract: The present invention relates to two novel, testis-specific proteins (C19 and C23) that arc lysozyme paralogues. The proteins are believed to play a role in capacitation of sperm and the fertilization of the ovum. Therefore these compounds make ideal targets for the design of contraceptive agents. The C19 and C23 proteins can also be modified to establish lysozyme activity and the modified proteins can then be used in all applications that currently exist for lysozymes.
    Type: Application
    Filed: July 18, 2002
    Publication date: July 10, 2003
    Inventors: John C. Herr, Friederike Jayes, Arabinda Mandal, Jagathpala Shetty, Michael J. Wolkowicz